Thrombin-jmi Kit
NDC Package 60793-705-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Thrombin-jmi (thrombin, topical (bovine)) kits is tHROMBIN-JMI is topical bovine thrombin indicated to aid hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical techniques (such as suture, ligature, or cautery) is ineffective or impractical.In various types of surgeries, solutions of THROMBIN-JMI may be used in conjunction with an Absorbable Gelatin Sponge, USP for hemostasis. This formulation utilizes a kit delivery system. Marketed by Pfizer Laboratories Div Pfizer Inc, this product is identified by NDC 60793-705 and is authorized under FDA application BLA102865.

Identification & Billing

NDC Package Code
60793-705-05
Package Description
1 KIT in 1 CARTON * 5 mL in 1 VIAL, GLASS (60793-315-01) * 5 mL in 1 VIAL, GLASS (60793-218-09)
Product Code
60793-705
11-Digit Billing Format
60793070505
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Thrombin-jmi
Non-Proprietary Name
Thrombin, Topical (bovine)
Dosage Form
Kit - A packaged collection of related material.
Usage Information
THROMBIN-JMI is topical bovine thrombin indicated to aid hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical techniques (such as suture, ligature, or cautery) is ineffective or impractical.In various types of surgeries, solutions of THROMBIN-JMI may be used in conjunction with an Absorbable Gelatin Sponge, USP for hemostasis.

Regulatory & Marketing

Labeler Name
Pfizer Laboratories Div Pfizer Inc
Product Type
Plasma Derivative
FDA Application #
BLA102865
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
02-24-1995
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 60793-705-05 identifies a specific commercial package of 1 kit in 1 carton * 5 ml in 1 vial, glass (60793-315-01) * 5 ml in 1 vial, glass (60793-218-09) of Thrombin-jmi, a plasma derivative labeled by Pfizer Laboratories Div Pfizer Inc. This kit is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pfizer Laboratories Div Pfizer Inc on February 24, 1995. The current certification is valid through December 31, 2027.

How is this Pfizer Laboratories Div Pfizer Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 60793070505. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
60793-705-05
11-Digit CMS (5-4-2)
60793-0705-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.